TrialCardiovascular diabetology2026

Inpatient safety, effectiveness of SGLT2 inhibitors and GLP-1 RAs in type 2 diabetes: ENDOCARE, a pragmatic prospective cohort study.

Óscar Moreno-Pérez et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.